Collaborative R&D to focus on innovation for patient-driven advances in cancer treatment

‘Human Emulation System’ offers a living platform to understand disease and design new cancer medicines

BOSTON, Mass. – Emulate, Inc. announced today its strategic collaboration with the Lawrence J. Ellison Institute for Transformative Medicine of USC to use Emulate’s Organs-on-Chips technology to conduct leading-edge translational R&D that can advance cancer treatment and patient well-being. Emulate and the Ellison Institute will collaborate on innovative approaches for modeling the human physiology of cancer and predicting human response to treatments, expanding the functionality and applications of using the Organs-on-Chips technology in cancer research. This R&D initiative is announced as part of Emulate’s growing network of collaborators and is designed to foster translational research to expand the range of academic, commercial and clinical applications for Emulate’s Human Emulation System™.